Considering the updated 2016 WHO classification, the significant role of TET2 mutation in haematological neoplasms, and data from our previous research, we performed this study mainly to understand if germline TET2 mutation has a family aggregation phenomenon and is a tumour predisposition gene. Here, TET2 is linked to hematopoietic and lymphoid cell neoplasm.